コンテンツへスキップ
Merck
  • Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9.

Stem cell research (2016-11-24)
Anne M Bara, Angelica Messana, Amanda Herring, Dane Z Hazelbaker, Kevin Eggan, Lindy E Barrett
要旨

Here, we generated a monoallelic mutation in the TLE3 (Transducin Like Enhancer of Split 3) gene using CRISPR-Cas9 editing in the human embryonic stem cell (hESC) line WA01. The heterozygous knockout cell line, TLE3-447-D08-A01, displays partial loss of TLE3 protein expression while maintaining pluripotency, differentiation potential and genomic integrity.

材料
製品番号
ブランド
製品内容

Roche
cOmplete、ミニ、プロテアーゼ阻害剤カクテル, Tablets provided in a glass vial
Sigma-Aldrich
モノクロナール抗アクチン, α-平滑筋, clone 1A4, ascites fluid
Sigma-Aldrich
ピューロマイシン 二塩酸塩 Streptomyces alboniger由来, ≥98% (HPLC), powder
Sigma-Aldrich
モノクロナール抗α-胎児タンパク質 (AFP) マウス宿主抗体, ascites fluid, clone C3